tm
Seeing Is Believing
tm
Seeing Is Believing
CNTX is currently covered by 2 analysts with an average price target of $5.87. This is a potential upside of $4.61 (365.87%) from yesterday's end of day stock price of $1.26.
Context Therapeutics's activity chart (see below) currently has 11 price targets and 15 ratings on display. The stock rating distribution of CNTX is 100% BUY.
Highest price target for CNTX is $9, Lowest price target is $9, average price target is $9.
Most recent stock forecast was given by JASON KOLBERT from D. BORAL CAPITAL on 15-Oct-2025. First documented stock forecast 01-Feb-2022.
Currently out of the existing stock ratings of CNTX, 3 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$9
$7.74 (614.29%)
11 days ago
(15-Oct-2025)
0/1 (0%)
$7.74 (614.29%)
Buy
2 months 20 days ago
(06-Aug-2025)
0/8 (0%)
$3.92 (188.46%)
Buy
$4
$2.74 (217.46%)
$4
1 years 5 months 18 days ago
(08-May-2024)
0/2 (0%)
$2.17 (118.58%)
What is CNTX (Context Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on CNTX (Context Therapeutics) with a proven track record?
Which analyst has the current lower performing score on CNTX (Context Therapeutics) with a proven track record?
Which analyst has the most public recommendations on CNTX (Context Therapeutics)?
Which analyst is the currently most bullish on CNTX (Context Therapeutics)?
Which analyst is the currently most reserved on CNTX (Context Therapeutics)?
